AFG
DGX icon

Atomi Financial Group’s Quest Diagnostics DGX Stock Holding History

Atomi Financial Group’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$812K Buy
3,830
+229
+6% +$44.9K 0.02% 555
2026
Q1 		$706K Buy
3,601
+19
+0.5% +$3.69K 0.02% 560
2025
Q4 		$622K Buy
3,582
+2,254
+170% +$410K 0.02% 597
2025
Q3 		$253K Buy
+1,328
New +$236K 0.01% 985

Other funds holding DGX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
EIG
EdgePoint Investment Group Toronto, Ontario, Canada $13.2B AUM 32.43% 1-Year Est. Return

Atomi Financial Group's DGX Position: Q2 2026 in Review

Atomi Financial Group increased its Quest Diagnostics (DGX) stake by 6.4% in Q2 2026, buying an estimated $44.9K and bringing the position to 3,830 shares worth $812K. The position accounts for 0.02% of the portfolio, ranked #555.

Atomi Financial Group first reported a position in DGX in Q3 2025 and has held it in 4 quarters since. 1,109 funds tracked by Wall St. Rank hold DGX as of Q2 2026.

  • Atomi Financial Group held 3,830 shares of Quest Diagnostics worth $812K as of Q2 2026.
  • Atomi Financial Group bought 229 Quest Diagnostics shares in Q2 2026, an estimated $44.9K.
  • Quest Diagnostics made up 0.02% of Atomi Financial Group's portfolio in Q2 2026, its #555 holding.
  • Atomi Financial Group first reported a position in Quest Diagnostics in Q3 2025 and has held it in 4 quarters since.
  • 1,109 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.

Based on Atomi Financial Group's 13F filing for Q2 2026, filed 4 Aug 2026.